数据与复现药物发现与化学信息学FreedomIntelligence/OpenClaw-Medical-Skills数据与复现
TO

tooluniverse-pharmacovigilance

维护者 FreedomIntelligence · 最近更新 2026年4月1日

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

OpenClawNanoClaw分析处理复现实验tooluniverse-pharmacovigilance🏥 medical & clinicalmedical toolsanalyze

原始来源

FreedomIntelligence/OpenClaw-Medical-Skills

https://github.com/FreedomIntelligence/OpenClaw-Medical-Skills/tree/main/skills/tooluniverse-pharmacovigilance

维护者
FreedomIntelligence
许可
MIT
最近更新
2026年4月1日

技能摘要

来自 SKILL.md 的关键信息

2 min

核心说明

  • Systematic drug safety analysis ,使用 FAERS adverse event data,FDA labeling,PharmGKB pharmacogenomics,、 clinical trial safety signals。
  • KEY PRINCIPLES:1. Report-first approach - Create report file FIRST,update progressively 2. Signal quantification - Use disproportionality measures (PRR,ROR) 3. Severity stratification - Prioritize serious/fatal events 4. Multi-source triangulation - FAERS,labels,trials,literature 5. Pharmacogenomic context - Include genetic risk factors 6. Actionable output - Risk-benefit summary ,支持 recommendations 7. English-first queries - Always use English drug names 、 search terms in tool calls,even if user writes in another language. Only try original-language terms as fallback. Respond in user's language。

原始文档

SKILL.md 摘录

When to Use

Apply when user asks:

  • "What are the safety concerns for [drug]?"
  • "What adverse events are associated with [drug]?"
  • "Is [drug] safe? What are the risks?"
  • "Should I be concerned about [specific adverse event] with [drug]?"
  • "Compare safety profiles of [drug A] vs [drug B]"
  • "Pharmacovigilance analysis for [drug]"

1. Report-First Approach (MANDATORY)

  1. Create the report file FIRST:

    • File name: [DRUG]_safety_report.md
    • Initialize with all section headers
    • Add placeholder text: [Researching...]
  2. Progressively update as you gather data

  3. Output separate data files:

    • [DRUG]_adverse_events.csv - Ranked AEs with counts/signals
    • [DRUG]_pharmacogenomics.csv - PGx variants and recommendations

2. Citation Requirements (MANDATORY)

Every safety signal MUST include source:

适用场景

  • 适合在asked about drug safety,adverse events,post-market surveillance,或 risk-benefit assessment时使用。

不适用场景

  • Do not rely on this catalog entry alone ,用于 installation 或 maintenance details。

相关技能

相关技能

返回目录
AA
数据与复现药物发现与化学信息学

aav-vector-design-agent

AAV vector design: capsid selection, promoter optimization, payload capacity.

OpenClawNanoClaw分析处理
FreedomIntelligence/OpenClaw-Medical-Skills查看
AG
数据与复现药物发现与化学信息学

agentd-drug-discovery

AgentD autonomous drug discovery: target identification, hit finding, ADMET optimization.

OpenClawNanoClaw分析处理
FreedomIntelligence/OpenClaw-Medical-Skills查看
BI
数据与复现药物发现与化学信息学

bio-clinical-databases-hla-typing

Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining…

OpenClawNanoClaw分析处理
FreedomIntelligence/OpenClaw-Medical-Skills查看
BI
数据与复现药物发现与化学信息学

bio-clinical-databases-pharmacogenomics

Query PharmGKB and CPIC for drug-gene interactions, pharmacogenomic annotations, and dosing guidelines. Use when predict…

OpenClawNanoClaw分析处理
FreedomIntelligence/OpenClaw-Medical-Skills查看